A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinoma harboring EGFR mutations. (Q54677327)
Jump to navigation
Jump to search
scientific article published in January 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinoma harboring EGFR mutations. |
scientific article published in January 2011 |
Statements
A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinoma harboring EGFR mutations. (English)
Hoon-Kyo Kim
Dong-Wan Kim
Se-Hoon Lee
Jong Seok Lee
Myung Ah Lee
Jin Hyoung Kang
Si Young Kim
Sang Won Shin
Dae Seog Heo
1 January 2011
71
1
65-69